Marloes van den Berg, Zhonghua Shi, Wout J. Claassen, Pleuni Hooijman, Christopher T. A. Lewis, Jesper L. Andersen, Robbert J. van der Pijl, Sylvia J. P. Bogaards, Stefan Conijn, Eva L. Peters, Leon P. L. Begthel, Bas Uijterwijk, Johan Lindqvist, Paul R. Langlais, Armand R. J. Girbes, Sandra Stapel, Henk Granzier, Kenneth S. Campbell, Weikang Ma, Thomas Irving, Darren T. Hwee, James J. Hartman, Fady I. Malik, Marinus Paul, Albertus Beishuizen, Julien Ochala, Leo Heunks, Coen A. C. Ottenheijm
{"title":"超松弛肌球蛋白有助于机械通气患者呼吸肌的冬眠。","authors":"Marloes van den Berg, Zhonghua Shi, Wout J. Claassen, Pleuni Hooijman, Christopher T. A. Lewis, Jesper L. Andersen, Robbert J. van der Pijl, Sylvia J. P. Bogaards, Stefan Conijn, Eva L. Peters, Leon P. L. Begthel, Bas Uijterwijk, Johan Lindqvist, Paul R. Langlais, Armand R. J. Girbes, Sandra Stapel, Henk Granzier, Kenneth S. Campbell, Weikang Ma, Thomas Irving, Darren T. Hwee, James J. Hartman, Fady I. Malik, Marinus Paul, Albertus Beishuizen, Julien Ochala, Leo Heunks, Coen A. C. Ottenheijm","doi":"10.1126/scitranslmed.adg3894","DOIUrl":null,"url":null,"abstract":"<div >Patients receiving mechanical ventilation in the intensive care unit (ICU) frequently develop contractile weakness of the diaphragm. Consequently, they may experience difficulty weaning from mechanical ventilation, which increases mortality and poses a high economic burden. Because of a lack of knowledge regarding the molecular changes in the diaphragm, no treatment is currently available to improve diaphragm contractility. We compared diaphragm biopsies from ventilated ICU patients (<i>N</i> = 54) to those of non-ICU patients undergoing thoracic surgery (<i>N</i> = 27). By integrating data from myofiber force measurements, x-ray diffraction experiments, and biochemical assays with clinical data, we found that in myofibers isolated from the diaphragm of ventilated ICU patients, myosin is trapped in an energy-sparing, super-relaxed state, which impairs the binding of myosin to actin during diaphragm contraction. Studies on quadriceps biopsies of ICU patients and on the diaphragm of previously healthy mechanically ventilated rats suggested that the super-relaxed myosins are specific to the diaphragm and not a result of critical illness. Exposing slow- and fast-twitch myofibers isolated from the diaphragm biopsies to small-molecule compounds activating troponin restored contractile force in vitro. These findings support the continued development of drugs that target sarcomere proteins to increase the calcium sensitivity of myofibers for the treatment of ICU-acquired diaphragm weakness.</div>","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"16 758","pages":""},"PeriodicalIF":15.8000,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patients\",\"authors\":\"Marloes van den Berg, Zhonghua Shi, Wout J. Claassen, Pleuni Hooijman, Christopher T. A. Lewis, Jesper L. Andersen, Robbert J. van der Pijl, Sylvia J. P. Bogaards, Stefan Conijn, Eva L. Peters, Leon P. L. Begthel, Bas Uijterwijk, Johan Lindqvist, Paul R. Langlais, Armand R. J. Girbes, Sandra Stapel, Henk Granzier, Kenneth S. Campbell, Weikang Ma, Thomas Irving, Darren T. Hwee, James J. Hartman, Fady I. Malik, Marinus Paul, Albertus Beishuizen, Julien Ochala, Leo Heunks, Coen A. C. Ottenheijm\",\"doi\":\"10.1126/scitranslmed.adg3894\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div >Patients receiving mechanical ventilation in the intensive care unit (ICU) frequently develop contractile weakness of the diaphragm. Consequently, they may experience difficulty weaning from mechanical ventilation, which increases mortality and poses a high economic burden. Because of a lack of knowledge regarding the molecular changes in the diaphragm, no treatment is currently available to improve diaphragm contractility. We compared diaphragm biopsies from ventilated ICU patients (<i>N</i> = 54) to those of non-ICU patients undergoing thoracic surgery (<i>N</i> = 27). By integrating data from myofiber force measurements, x-ray diffraction experiments, and biochemical assays with clinical data, we found that in myofibers isolated from the diaphragm of ventilated ICU patients, myosin is trapped in an energy-sparing, super-relaxed state, which impairs the binding of myosin to actin during diaphragm contraction. Studies on quadriceps biopsies of ICU patients and on the diaphragm of previously healthy mechanically ventilated rats suggested that the super-relaxed myosins are specific to the diaphragm and not a result of critical illness. Exposing slow- and fast-twitch myofibers isolated from the diaphragm biopsies to small-molecule compounds activating troponin restored contractile force in vitro. These findings support the continued development of drugs that target sarcomere proteins to increase the calcium sensitivity of myofibers for the treatment of ICU-acquired diaphragm weakness.</div>\",\"PeriodicalId\":21580,\"journal\":{\"name\":\"Science Translational Medicine\",\"volume\":\"16 758\",\"pages\":\"\"},\"PeriodicalIF\":15.8000,\"publicationDate\":\"2024-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Science Translational Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.science.org/doi/10.1126/scitranslmed.adg3894\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/scitranslmed.adg3894","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patients
Patients receiving mechanical ventilation in the intensive care unit (ICU) frequently develop contractile weakness of the diaphragm. Consequently, they may experience difficulty weaning from mechanical ventilation, which increases mortality and poses a high economic burden. Because of a lack of knowledge regarding the molecular changes in the diaphragm, no treatment is currently available to improve diaphragm contractility. We compared diaphragm biopsies from ventilated ICU patients (N = 54) to those of non-ICU patients undergoing thoracic surgery (N = 27). By integrating data from myofiber force measurements, x-ray diffraction experiments, and biochemical assays with clinical data, we found that in myofibers isolated from the diaphragm of ventilated ICU patients, myosin is trapped in an energy-sparing, super-relaxed state, which impairs the binding of myosin to actin during diaphragm contraction. Studies on quadriceps biopsies of ICU patients and on the diaphragm of previously healthy mechanically ventilated rats suggested that the super-relaxed myosins are specific to the diaphragm and not a result of critical illness. Exposing slow- and fast-twitch myofibers isolated from the diaphragm biopsies to small-molecule compounds activating troponin restored contractile force in vitro. These findings support the continued development of drugs that target sarcomere proteins to increase the calcium sensitivity of myofibers for the treatment of ICU-acquired diaphragm weakness.
期刊介绍:
Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research.
The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases.
The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.